Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer

In the present study, we aimed to evaluate the association of circulating AR copy number (CN) and outcome in a cohort of patients with advanced castration-resistant prostate cancer (CRPC) treated with enzalutamide after docetaxel. Fifty-nine CRPC patients were evaluated. AR CN was analyzed with real...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvi, Samanta, Casadio, Valentina, Conteduca, Vincenza, Lolli, Cristian, Gurioli, Giorgia, Martignano, Filippo, Schepisi, Giuseppe, Testoni, Sara, Scarpi, Emanuela, Amadori, Dino, Calistri, Daniele, Attard, Gerhardt, Giorgi, Ugo De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122353/
https://www.ncbi.nlm.nih.gov/pubmed/27191887
http://dx.doi.org/10.18632/oncotarget.9341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122353/
https://www.ncbi.nlm.nih.gov/pubmed/27191887
http://dx.doi.org/10.18632/oncotarget.9341

Ejemplares similares